Drug intelligence / Profile preview

Ganmaoling Granules

Development stage
Unknown
Lead developer
China Resources Sanjiu Medical & Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Ganmaoling Granules is a widely used Chinese patent medicine formulated for the treatment of the common cold and influenza. It is a hybrid combination preparation that blends traditional Chinese medicine (TCM) herbal extracts with Western pharmaceutical active ingredients. The formulation typically contains paracetamol (acetaminophen) as an antipyretic and analgesic, chlorphenamine (chlorpheniramine maleate) as an antihistamine to relieve nasal congestion and runny nose, and caffeine to counteract drowsiness. These are combined with heat-clearing and detoxifying TCM herbs, including *Evodia lepta* (Sanchaku), *Ilex asprella* (Gangmei), *Chrysanthemum indicum* (wild chrysanthemum), and *Bidens pilosa* (Calendula Yinpan), along with peppermint oil. It is administered orally as dissolvable granules in hot water to relieve symptoms such as headache, fever, sore throat, and nasal congestion.

Brand names
999 Ganmaoling Granules999 Sanjiu Ganmaoling GranulesGanmaoling Granules (999)
Other names
999 GanmaolingGanmaoling
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Ganmaoling Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganmaoling Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call